Explore

Ligand Cancer 2018

International Conference on Cancer and Radiology 2018

Dubai, United Arab Emirates
12 - 14 November 2018
The conference ended on 14 November 2018

Important Dates

Abstract Submission Deadline
31st October 2018
Final Abstract / Full Paper Deadline
31st October 2018
Early Bird Deadline
10th November 2018

About Ligand Cancer 2018

Ligand International invites all the participants across the globe to attend ‘International Conference on Cancer and Radiology’ of Nov 12 -14, 2018 at Dubai, UAE. which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Topics

Cancer and diet, Cancer biology, Cancer and cell biology, Cancer cells research

Call for Papers

Ligand International invites all the participants across the globe to attend ‘International Conference on Cancer and Radiology’ of Nov 12 -14, 2018 at Dubai, UAE. which includes prompt keynote presentations, Oral talks, Poster presentations and Exhibitions.

Ligand Cancer 2018 coordinates towards tending to main issues as well as future strategies of Cancer. This will be the biggest and most encouraging universal gathering where the program incorporates Clinical Oncologists, Registered Nurses, Nurse specialists and the whole restorative group required in patient care, scientists, proficient, early profession people who wish to learn standards of tumor immunology and immunotherapy well as leaders will come to examine on different parts of challenges, risks and investment opportunities of Cancers. Ligand Cancer at Dubai will manage Cancer Prevention, Diagnosis, and Treatment of illnesses of the Organ-related Cancers and its inventive strategies. Ligand Cancer will also provide the three days of discussions on techniques and systems identified with administration and quality change of Cancer and in addition to investigate the new thoughts and ideas on worldwide scale and the themes incorporate lung malignancy, bosom disease, bone tumor, leukemia, blood cancer, cervical tumor, colon-rectum disease, pediatric malignancy, surgical tumor, Prostate growth, thyroid malignancy.

Keep Up to Date with PaperCrowd

Sign up and follow your favorite conferences.

We are no longer accepting conference submissions on PaperCrowd. We apologise for any inconvenience.